What to Watch With PepsiCo (PEP) Stock in 2026

PepsiCo has underperformed for three consecutive years through end-2024 as weakness in its food arm—Frito-Lay saw slipping revenue/volume and Quaker’s revenue and volume fell roughly 14% last year—has dragged on the business, prompting a suite of strategic moves: full ownership and heavier promotion of Sabra, dye-free Cheetos and Doritos, the March acquisition of prebiotic soda Poppi and July launch of a prebiotic cola, plus plans to cut beverage-unit operating costs and trim SKUs by about 20% to free marketing dollars. Management is clearly pursuing a turnaround focused on healthier and innovation-led SKUs and reallocated marketing spend; analysts model only modest recovery (consensus ~3.4% revenue growth in 2026 and EPS rising from $8.11 to $8.58), meaning even small, measurable gains in sales and volumes will be material for restoring investor confidence, while any further shortfall could trigger a sharper reassessment of PepsiCo’s outlook.

Analysis

PepsiCo (PEP) has underperformed equities markets for three consecutive years through end-2024, with the share price still slightly down since that date as weakness in its food segment has pressured results. Frito-Lay reported modest revenue and volume declines last year while Quaker saw revenue and volume tumble roughly 14%, creating the primary drag on consolidated performance and investor sentiment.

Management has enacted a clear strategic response: completing ownership and heavier promotion of Sabra, launching dye-free Cheetos and Doritos in July, acquiring prebiotic soda Poppi in March and introducing a prebiotic cola in July, and announcing a beverage-unit cost program including a roughly 20% SKU reduction to reallocate spend into advertising. These moves target healthier product positioning and marketing-led demand stimulation but require visible consumer adoption to prove efficacy.

Analysts model only a modest recovery — consensus revenue growth of about 3.4% in 2026 and EPS rising from an expected $8.11 this year to $8.58 next year — so even small, measurable improvements in sales and volumes would materially restore confidence. Investors face binary outcomes: measurable U.S. and international sales/volume gains would validate the turnaround, while continued stagnation or missed targets could prompt a sharper re-rating given low market sentiment and limited margin for error.

Key Decisions for Investors

• Wait for at least one quarter of consistent sales and volume growth in Frito-Lay and Quaker before increasing exposure to PEP
• If already invested, cap position size and consider tactical hedges until management demonstrates progress toward the 3.4% 2026 revenue consensus and EPS recovery to ~$8.58
• Monitor early adoption metrics for Poppi/prebiotic cola and the impact of the 20% SKU reduction and reallocated marketing spend over the next 3-6 months and add to positions only on clear, sustained improvement